DESIGNING AND EVALUATION OF FLURBIPROFEN SODIUM SUPPOSITORIES
DOI:
https://doi.org/10.22159/ijcpr.2023v15i6.3082Keywords:
Cocoa butter, Flurbiprofen sodium, In vitro release study, PEG 4000 and 6000, Rectal dosage form, SuppositoryAbstract
Objective: The present investigation was aimed to develop Flurbiprofen Sodium suppositories by using different suppository bases with a view to avoid loss of drug by first pass effect and to minimize toxic effects, thereby producing safe and effective dosage form which will improve the solubility and absorbability of poorly soluble drug.
Methods: Fusion method was used for the preparation of suppositories. Pre formulation studies of the drug was done by determining its physical appearance, melting point, IR spectrum, UV spectrum and solubility studies of Flurbiprofen sodium were carried out in different Solvents.
Results: Melting point of Flurbiprofen sodium was found to be in the range 114 °C-117 °C. UV spectrum of Flurbiprofen sodium in ethanol at pH7.4 was determined at 273 nm. Calibration curve of Flurbiprofen sodium in pH 6.4 phosphate buffer were constructed in the concentration range of 0-20 μg/ml. The prepared suppositories of each batch was evaluated for their physio-chemical properties like weight variation, Hardness, Friability, length and width, melting point, breaking strength, disintegration test, content uniformity, in vitro drug release and stability studies. The prepared suppositories were smooth and fine in texture with mechanical strength (hardness) i.e. can tolerate less than 5.0 kg. The friability was found to be within acceptable limits (less than 1%).
Conclusion: Suppositories were successfully formulated and evaluated. The type of base employed for the preparation of suppositories influenced the release of the drug during the dissolution studies. They can be arranged in order of release rate as-PEG 4000>PEG 6000>Cocoa butter. The use of Sodium lauryl sulphate also influenced the release rate of the drug and the release rate patterns of all formulations.
Downloads
References
Robert EK. Dispensing of medication. 9th ed. Easton PA: Mack Publishing Company; 1984. p. 87-99.
El Majri MA, Sharma RK. Formulation and evaluation of piroxicam suppositories. Int J Drug Delivery. 2010;2(2):108-12. doi: 10.5138/ijdd.2010.0975.0215.02019.
Lachman L, Liberman HA, Kanig JL. The theory and practice of Industrial Pharmacy. 3rd ed. Bombay: Varghese Publishing House; 1987. p. 564-88.
Brooks CD, Linet OI, Schellenberg D, Turner LF, Defesche CL, Teoh KW. Clinical safety of flurbiprofen. J Clin Pharmacol. 1990 Apr;30(4):342-51. doi: 10.1002/j.1552-4604.1990.tb03604.x, PMID 2187910.
Devi PN, Bonthu S, Neerukonda V, Pasha SI, Poloju Deepthi AMD, Rajeev KM. Flurbiprofen microbeads for controlled relaease. Int J Pharm Chem Biol Sci. 2013;3(3):586-94.
Varshney Himanshu M, Tanwar YS. Designing, release characteristics and in vitro evaluation of flurbiprofen sodium suppositories. Int J Pharm Clin Res. 2009;1(1):31-4.
Barar FSK. Essentials of pharmacotherapeutics. S. Chand and company Ltd. New Delhi; 2003. p. 127.
The United States pharmacopoeia (USP) 30. NF 25. The United States Pharmacopeia Convention Inc: USA; 2006. p. 276.
Carter SJ. Cooper and Gunn’s-dispensing for pharmaceutical students. 12th ed. CBS publishers and distributors. Delhi; 1987. p. 232-52.
Pugunes S, Ugandar RE. Formulation and evaluation of natural palm oil-based diclofenac sodium suppositories. Int J Pharm Sci Res. 2013;4(2):617-21.
Ibrahim SA, El-Faham TH, Tous SS, Mostafa EM. Formulation, release characteristics and evaluation of ibuprofen suppositories. International Journal of Pharmaceutics. 1990;61(1-2):1-7. doi: 10.1016/0378-5173(90)90037-5.
Gulzar Md A, Venkatesh GK, Udupa N. Formulation and evaluation of compressed suppositories of indomethacin. Indian J Pharm Sci. 2000;62(3):196-9.
Published
How to Cite
Issue
Section
Copyright (c) 2023 RUMITA KUMAWAT, KAMAL S. RATHORE, MEENAKSHI BHARKATIYA
This work is licensed under a Creative Commons Attribution 4.0 International License.